Lisa Ann Rometty - 03 Jan 2022 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
Director
Signature
/s/ Josh Seidenfeld, Attorney-in-Fact for Lisa Ann Rometty
Issuer symbol
RANI
Transactions as of
03 Jan 2022
Net transactions value
$0
Form type
4
Filing time
05 Jan 2022, 17:55:16 UTC
Next filing
27 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RANI Stock Option (Right to Buy) Award $0 +49,037 $0.000000 49,037 03 Jan 2022 Class A Common Stock 49,037 $17.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vest on January 3, 2023; and 1/36th of the shares subject to the option vest monthly thereafter over the following two years.